Lataa...
PD-1/PD-L1 Blockade after Transient Lymphodepletion to Treat Myeloma
Early phase clinical trials targeting the programmed death receptor-1/ligand-1 (PD-1/PD-L1) pathway to overcome tumor-mediated immunosuppression have reported promising results for a variety of cancers. This pathway appears to play an important role in the failure of immune reactivity to malignant p...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2013
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3891840/ https://ncbi.nlm.nih.gov/pubmed/23616570 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1202005 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|